Document is current
Any future updates will be listed below
-
Authors
Lee, Chung-Han
Motzer, Robert
- License Information
-
More Information
Article History
Received: 17 May 2018
Revised: 15 June 2018
Accepted: 15 June 2018
First Online: 17 October 2018
Competing interests
: C.-H.L.: Consulting (Exelixis, Eisai), and Research Funds to the Institute (BMS, Exelixis, Pfizer, Calithera, Eisai). R.J.M.: Consulting (Novartis, Pfizer, Eisai, Exelixis), and research funds to the institute (Novartis, Pfizer, Eisai, Exelixis, BMS, Genetech/Roche).
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License).
Free to read: This content has been made available to all.
